Viewing Study NCT01769768


Ignite Creation Date: 2025-12-24 @ 6:28 PM
Ignite Modification Date: 2025-12-28 @ 3:09 PM
Study NCT ID: NCT01769768
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2013-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module